Delivery Order SPE2DB22D2007-SPE2DB25FJ3LT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,886.77 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on June 4, 2025, with an ultimate completion date of June 5, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,028.16 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.14 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60 count) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger federal pharmaceutical supply agreements. The work will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $25,905.55 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single line item fulfilling pharmaceutical supply...
- The Defense Logistics Agency awarded a $4,865.97 delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 4, 2025, with completion targeted for September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this...
- The Defense Logistics Agency awarded a $12,241.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract was competitively awarded and performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,723.80 to AmerisourceBergen Drug Corp for the supply of IBSRELA 50 mg tablets (60-count units) to be delivered to the company's facility in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on May 30, 2025, with an ultimate completion date of June 2, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,477.01 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 10, 2025, for IBSRELA 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $5,261.40 with a completion date of July 11, 2025, was competitively awarded with no set-aside designation. The award represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,971.92 to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger relationship...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3LTDelivery Order
The Defense Logistics Agency awarded a $10,409.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for IBSRELA 50 mg tablets (60-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-competitive delivery order was performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company's DLA Troop Support Medical IDC enables it to fulfill pharmaceutical requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies the company's ongoing role in supporting the military healthcare supply chain through the flexible and competitively established prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 7/30/25 |